Submit Deal

STAR THERAPEUTICS INC

HQ - South San Francisco

Summary

Star Therapeutics is a biotechnology company engaged in discovering and developing novel therapies for rare diseases through its portfolio of innovative biotech companies.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 93 M

Avg. Deal Size£ 93 M

Market Context

Senior Management

Adam Rosenthal
CEO and Founder

Sort

06 Oct 2025|United States|Biotechnology

Target: STAR THERAPEUTICS INC

Bidder: VIKING GLOBAL INVESTORS

7 Service Providers

1 Target | 6 Bidder

7 Dealmakers

1 Target | 6 Bidder

£ 92 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy